Why is Zenith Drugs falling/rising?

As of 04-Jul, Zenith Drugs Ltd is experiencing a price increase, with its current price at 75.50, reflecting a rise of 3.55 or 4.93%. The stock has shown strong performance recently, outperforming its sector by 4.42% today. Over the past week, the stock has gained 11.03%, while it has increased by 11.11% over the past month. However, despite this positive short-term performance, the stock is down 6.56% year-to-date, indicating a mixed longer-term trend. Notably, the stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 79.65% compared to the 5-day average, which may suggest waning interest among investors.
In the broader market context, while Zenith Drugs has outperformed the Sensex by a considerable margin in the short term, the benchmark index has shown a positive return of 3.42% over the past month. This indicates that while Zenith Drugs is gaining traction relative to its sector, it is still facing challenges in the longer-term performance compared to the overall market, as evidenced by its year-to-date decline versus the Sensex's gain of 7.68%. The liquidity of the stock remains adequate for trading, but the falling delivery volume could be a concern for sustained upward momentum. Overall, the stock's recent rise can be attributed to short-term gains, but the significant drop in investor participation may pose risks for future performance.